Abstract

In recent years, crystallographic fragment screening has matured into an almost routine experiment at several modern synchrotron sites. The hits of the screening experiment, i.e. small molecules or fragments binding to the target protein, are revealed along with their 3D structural information. Therefore, they can serve as useful starting points for further structure-based hit-to-lead development. However, the progression of fragment hits to tool compounds or even leads is often hampered by a lack of chemical feasibility. As an attractive alternative, compound analogs that embed the fragment hit structurally may be obtained from commercial catalogs. Here, a workflow is reported based on filtering and assessing such potential follow-up compounds by template docking. This means that the crystallographic binding pose was integrated into the docking calculations as a central starting parameter. Subsequently, the candidates are scored on their interactions within the binding pocket. In an initial proof-of-concept study using five starting fragments known to bind to the aspartic protease endothiapepsin, 28 follow-up compounds were selected using the designed workflow and their binding was assessed by crystallography. Ten of these compounds bound to the active site and five of them showed significantly increased affinity in isothermal titration calorimetry of up to single-digit micromolar affinity. Taken together, this strategy is capable of efficiently evolving the initial fragment hits without major synthesis efforts and with full control by X-ray crystallography.

Highlights

  • In a drug-discovery project, the hits obtained by fragment screening are typically smaller than the lead-like molecules obtained from a high-throughput screening (HTS) campaign

  • Based on a crystal structure of a fragment hit, structurally homologous compounds are retrieved from the catalog of commercially available compounds, in this case MolPort

  • An informed selection of follow-up candidates was performed in a PyMOL session (PyMOL version 2.0; Schrodinger), highlighting favorable contact distances, per-atom contributions to the overall DSX score and molecular properties that are relevant for fragment-based lead discovery (FBLD)

Read more

Summary

Introduction

In a drug-discovery project, the hits obtained by fragment screening are typically smaller than the lead-like molecules obtained from a high-throughput screening (HTS) campaign. Fragments constitute excellent starting points for lead discovery as they usually explore the hotspots of binding, where a large part of the binding affinity can be obtained. It is clear, that owing to their small size and their weak binding affinity, fragments need to be improved with respect to affinity and specificity. That owing to their small size and their weak binding affinity, fragments need to be improved with respect to affinity and specificity Due to their rather small number of interactions with the protein surface, fragments are often promiscuous binders.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.